not bad now lets see how they handle things from here. seems to me they are a little slow on their word, but they also seem to keep their promises at the same time
On July 8th,2010 this was released..some things I love some I dont..I would LOVE to hear those revenue projections,and i would love to hear that the second place leased is their offical dispensery,along with a nice date of GRAND OPENING! it would seem logical.would love to see all those nice different cannibis products also as well as PICTURES OF LAB EQUIPIMENT and maybe a nice amazon jungle looking atmosphere(LARGE TREES EVERYWHERE!!!)regardless it seems like MY OPINION that this can only be the bottom,we cant go back to low .05 and upper .04s with all this goin on,gimmie a break,but i have been wrong before....watcha fellas think?
ONE LOVE AND GOD BLESS!
Dr. Robert Melamede, Ph.D., Cannabis Science President and CEO, stated, "Having all of these operations in one secure, state-licensed facility will greatly increase our ability to provide patients with affordable cannabis based medicines and to determine what they find to be most effective in treating their medical problems. In addition to organic herbal cannabis, we will also be producing extracts, infusions such as tinctures, as well as edibles, which many patients prefer when they have confidence in their source. Quality control and the ability to develop standardized products are the essential keys to moving forward with both medical marijuana under state laws, as well as being the basis of any pharmaceutical formulations we will submit for FDA clinical trials."
Richard Cowan, Cannabis Science CFO, explained, "The revenue potential from this facility is obviously very significant, and we will make public our estimates on the projected revenue in the near future, but, as with our previously announced acquisitions in Colorado and Montana, our main focus will remain on R&D. As Dr. Melamede has pointed out, previously new biotech companies have never known whether their proposed products were safe and effective until they were submitted for FDA clinical trials. Now Cannabis Science, working in states with medical marijuana laws, is changing the paradigm. We will know that the products we submit for clinical trials will be what the patients want and need. This new facility is a key part of our corporate strategy."
News 
Market Data 
Discover 
AI
